Leading medical organizations team up to bring new TB treatments to those in need
03/19/2015. International organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD) and their financial partner UNITAID will start in April the endTB project, a partnership aimed at radically changing the management of multidrug-resistant tuberculosis (MDR-TB).
By 2019, endTB will provide access to two new anti-TB drugs (bedaquiline and delamanid), for 2,600 MDR-TB patients in 16 countries. These are the first new anti-TB drugs developed in over 50 years and these drugs offer new hope to patients suffering from MDR-TB.
Read the article on MSF website
Related Articles
US foreign aid cuts: what could impact be?
04/28/2017. A leaked State Department budget document lays out proposals for a 30.8 percent cut in development aid and plans to sharply cut back.
Record $10 billion pledged in humanitarian aid for Syria at UN co-hosted conference in London
02/04/2016. Ban Ki-moon laid out three main objectives: raising $7 billion in immediate humanitarian aid, mustering long-term support, and protecting civilians.
What is the role of philanthropy in Covid times?
05/25/2020. Private generosity is on the rise. But while it can inspire state actors, it cannot replace them.
